Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 16,181

Document Document Title
WO/2023/031199A1
The present invention relates to malonamide compounds of the formula (I) where the variables are as defined in the claims and the description, and to compositions comprising these compounds. The invention also relates to the use of the s...  
WO/2023/031200A1
The present invention relates to malonamide compounds of the formula (I) where the variables are as defined in the claims and the description, and to compositions comprising these compounds. The invention also relates to the use of the s...  
WO/2023/027118A1
This resist composition generates an acid when being exposed to light and changes the solubility with respect to a developer through the action of the acid. The resist composition contains a compound including a cation (C0) represented b...  
WO/2023/026884A1
To provide a curable composition that generates little outgas from an obtained cured product. The curable composition includes a radical polymerization initiator represented by formula 1 and a radical polymerizable compound. In formula 1...  
WO/2023/028237A1
The disclosure provides novel solid state forms of Compound I chosen from Compound I Phosphate Salt Hydrate Form A, Compound I free form Monohydrate, Compound I Phosphate Salt Methanol Solvate, and Compound I Phosphate Salt MEK Solvate, ...  
WO/2023/028117A1
A method of treating a Cisd2 insufficiency-associated disorder. The method includes administering to a subject in need a compound of formula (I). Also disclosed is a method of increasing Cisd2 gene expression.  
WO/2023/027479A1
The present application provides: a heterocyclic compound which can significantly improve the service life, efficiency, electrochemical stability, and thermal stability of an organic light-emitting device; and an organic light-emitting d...  
WO/2023/027173A1
Provided are a compound represented by formula (1) (in formula (1), N*, R1-R9, L1, L2, L3, Ar1, and Ar2 are as defined in formula (1)), an organic electroluminescent element including the compound, and an electronic device including such...  
WO/2023/022233A1
The present invention provides: a fused ring compound which has a high glass transition temperature; a charge transport material for photoelectric conversion elements for imaging elements or a charge blocking material for photoelectric c...  
WO/2023/022417A1
Provided is a cyano group-substituted heteroaryl amine derivative which effectively absorbs high-energy external light source in the UV region to minimize damage to organic materials inside an organic electroluminescent device, thus cont...  
WO/2023/016249A1
The present invention relates to a method for preparing a 3-aryloxy-3-five-membered heteroaryl-propylamine compound. Specifically, provided in the present invention is a method for preparing a compound of formula I. The method comprises ...  
WO/2023/018052A1
Provided is a tertiary amine derivative, which effectively absorbs a high-energy external light source in a UV region so as to minimize damage to organic materials in an organic electroluminescent device, and thus contributes to a substa...  
WO/2023/017269A1
The invention relates to compounds of formula (I) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: (I) wherein RA and RB are as defined herein.  
WO/2023/016434A1
Provided are compounds of formula (I) which can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. Also provided are pharmaceutical compositions compr...  
WO/2023/013273A1
This fused ring compound C has a fused ring F that includes a plurality of monocyclic aromatic rings M. The fused ring F has 11 monocyclic aromatic rings M. Of the 11 monocyclic aromatic rings, no more than two are thiophene. The fused r...  
WO/2023/011028A1
The present invention relates to an organic compound, an electronic component and an electronic device. The structural formula of the organic compound of the present invention is represented by formula (I), and when used in an organic el...  
WO/2023/013592A1
A resist composition is adopted that contains a resin component, which has a constituent unit represented by general formula (a0-1), and a compound, which is represented by general formula (d0-1). In general formula (a0-1), R0 is a hydro...  
WO/2023/004964A1
Disclosed in the present invention is a method for synthesizing 3-bromomethyl-7-chlorobenzo[b]thiophene, the method comprising the following steps: adding a substrate of 3-methyl-7-chlorobenzo[b]thiophene into a C6-C8 straight-chain alka...  
WO/2023/003234A1
The present invention provides: a novel compound capable of improving the luminous efficiency, stability and lifespan of an element; an organic electric element using same; and an electronic device thereof.  
WO/2023/003014A1
The present disclosure provides, for example, a method for producing 2-(4-cyclopropyl-2-fluoroanilino)-3,4-difluoro-5-[[3-fluoro- 2-(methylsulfamoylamino)pyridin-4-yl]methyl]benzamide or a pharmacologically acceptable salt thereof, or a ...  
WO/2023/003313A1
The present invention relates to: an organic compound which is used for an organic layer, such as a hole transport layer or an electron blocking layer, in an organic light-emitting device; and an organic light-emitting device comprising ...  
WO/2023/000435A1
A method for preparing a sertaconazole nitrate intermediate. Cyclohexane is used as a solvent, and in the presence of benzoyl peroxide, 3-methyl-7-chlorobenzo[b]thiophene reacts with a bromination reagent to generate 3-bromomethyl-7-chlo...  
WO/2023/288013A2
The present invention is directed to novel chemical compositions of matter, and in particular novel MDMA class of compounds having substituted methylenedioxyphenethylamine and substituted amphetamine, having a metabolically labile thioet...  
WO/2023/286057A1
Novel chemical compounds having herbicidal activity, agricultural compositions, process for their manufacture and their use in crop protection are provided.  
WO/2023/285788A1
A process for preparing a compound of formula (I), or a salt thereof, as defined herein. Also, compounds of formula I and intermediate compounds useful in the preparation of a compound of formula (I).  
WO/2023/279426A1
A polysubstituted selenium-containing cyclopent(hex)ene framework derivative and a synthesis method therefor. An arylacetylene compound and an unsaturated selenide reagent are used as reaction raw materials, and, under the action of a fr...  
WO/2023/279280A1
Disclosed in the present invention are an inhibitor of 1-methyl-7-chloro-4-((methoxyaryl heteroyl)amino)-N-(arylsulfonyl)-indole-2-carboxamide FBPase having a novel structure, a preparation method therefor, and a pharmaceutical compositi...  
WO/2023/282045A1
The present disclosure provides a compound represented by general formula (I). (I) (In the formula, Ara is a group obtained by removing n1 hydrogen atoms from a structure represented by general formula (A), and is bonded to R1 at a porti...  
WO/2023/273997A1
An organic compound and an application thereof. The organic compound has a structure represented by formula I, has better stability and photoelectric properties, and can enhance and balance carrier transport, thereby improving device per...  
WO/2022/267661A1
The present application belongs to the field of organic materials, and relates to an organic compound, and an electronic element and an electronic device using same. The organic compound has a structure as represented by formula 1, and t...  
WO/2022/265034A1
The resist composition comprises a resin component (A1) and a compound (B0) represented by general formula (b0) (In the formula, X0 is a bromine atom or iodine atom. Rm is a hydroxy group, etc. nb1 is 1 to 5, nb2 is 0 to 4, and 1 ≤ nb1...  
WO/2022/265002A1
Provided is a resist composition comprising: a resin component having a constituent unit (a01a) having a polycyclic lactone-containing ring group and a constituent unit (a02) represented by general formula (a0-2); and a compound (B0) rep...  
WO/2022/264941A1
A resist composition which contains: a resin component (A1) having a constituent unit (a01) that contains an acid-cleavable group represented by formula (a01-r); and an acid generator component (B) that contains a compound (B0) represent...  
WO/2022/262365A1
The present application relates to an organic compound, and an electronic element and electronic device comprising same. The structural formula of the organic compound of the present application is represented by formula 1, and the appli...  
WO/2022/262657A1
The present invention relates to an N-substituted phenylsulfonamide compound and a use thereof. Specifically, the present invention provides a compound represented by formula I, or an optical isomer thereof, or a racemate thereof, or a p...  
WO/2022/257584A1
The present invention relates to a compound, which has a structural formula shown in formula (I) and is suitable for use in electronic components, especially in organic electroluminescence devices, and relates to a material for organic e...  
WO/2022/260240A1
The present specification provides a heterocyclic compound represented by chemical formula 1, and an organic light-emitting device comprising same.  
WO/2022/259886A1
The present invention provides: a compound and a material for organic electroluminescent elements, the compound and material further improving the performance of an organic EL element; an organic electroluminescent element which has furt...  
WO/2022/260096A1
Provided is a photoelectric conversion element material that is for an imaging element and that contributes to production of a photoelectric conversion element that is for an imaging element and that exhibits excellent dark current and e...  
WO/2022/255900A1
The present invention relates to the field of organic chemistry and pharmaceutics, and more particularly to ligands of the cysteinyl leukotriene receptors CysLT1R and CysLT2R, having the given formulae, where R1, R2, R3 and R4 have the v...  
WO/2022/255499A1
The purpose of the present invention is to provide a novel AMP-activated protein kinase activator. The present invention relates to a compound represented by formula (I): [wherein each symbol is as defined in the description], or a salt ...  
WO/2022/254034A1
The present invention concerns a compound having the formula (I), wherein: R1 is selected from the group consisting of: H, F, (C1-C6)alkoxy, and halo(C1-C6)alkyl; and R2 is an optionally substituted heteroaryl group, as well as processes...  
WO/2022/255235A1
The present invention addresses the problem of providing: a novel metal organic structure having gas storage capability; and a gas-storing agent and a gas storage method, in each of which the metal organic structure is used. Provided i...  
WO/2022/246662A1
The present disclosure relates to the technical field of display, and provides an organic compound and a light-emitting device. The structure of the organic compound is as represented by formula 1, formula 2 or formula 3. According to th...  
WO/2022/250957A2
Provided herein are compounds, thioester prodrugs thereof, compositions, and methods for the treatment of diseases and disorders associated with renal anomalies.  
WO/2022/244983A1
The present invention relates to a heterocyclic compound represented by chemical formula 1, an organic light-emitting element comprising same, methods for manufacturing same, and a composition for an organic material layer.  
WO/2022/245781A1
Disclosed is a method for generating nitroxyl (HNO) in the gas phase, the method comprising contacting a solid base-catalyzed HNO donor with a gaseous base; or a solid acid-catalyzed HNO donor with a gaseous acid; to form HNO in the gas ...  
WO/2022/243158A1
The present invention relates to a compound of Formula (I), (I) wherein R1, R2 and R3 are as defined herein and its use as a herbicide. The invention further relates to herbicidal compositions which comprise a compound of Formula (I) and...  
WO/2022/237780A1
An amide derivative and the pharmaceutical use thereof, in particular, the present invention relates to an amide derivative of formula (I) or a pharmaceutically acceptable salt thereof or all stereoisomers, tautomers and deuterated compo...  
WO/2022/237782A1
Provided are an amide derivative of formula (I), or a pharmaceutically acceptable salt thereof, or all stereoisomers, tautomers, and deuterated products thereof, and a pharmaceutical composition comprising the compound. The compound or c...  

Matches 201 - 250 out of 16,181